research and development
AstraZeneca’s Chris Brinsmead and ex-health minister Lord Darzi appointed ambassadors for UK lifescience
December 15, 2009Research and Development, Sales and Marketing AstraZeneca, Darzi, UK, appointment, research and development, sales and marketing
AstraZeneca UK’s chairman Chris Brinsmead and former health minister Lord Ara Darzi are among six newly appointed private sector business …
BIA appoints Nigel Gaymond chief executive
December 11, 2009Research and Development BIA, appointment, biotech, research and development
The BioIndustry Association (BIA) has appointed Nigel Gaymond as its new chief executive.
Chiltern appoints Dr Sharon Moore executive VP of global quality and medical affairs
December 10, 2009Research and Development appointment, chiltern, research and development
Chiltern has appointed Dr Sharon Moore executive VP, global quality and medical affairs.
Dr Yvonne Lamb to join Norgine as director of global pharmacovigilance
December 8, 2009Research and Development, Sales and Marketing Norgine, appointment, research and development, sales and marketing
Norgine has appointed Dr Yvonne Lamb as director, global pharmacovigilance, with effect from January 25 2010. A qualified physician, Yvonne …
Oxford BioTherapeutics appoints Dr Jim Cornett, Dr Jon Terrett and Dr Mike Gresser
December 2, 2009Research and Development Oxford Biotherapeutics, appointment, research and development
Oxford BioTherapeutics has expanded its US operations, recruiting a number of senior industry leaders.Dr Jim Cornett will head up operations …
Hervé Duchesne de Lamotte, chief financial officer, ExonHit Therapeutics
December 1, 2009Research and Development ExonHit Therapeutics, appointment, research and development
ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer.The Paris-based company develops innovative molecular diagnostic tests and therapeutics for …
Pfizer UK’s Zubair Hussain appointed president-elect of TOPRA
November 27, 2009Research and Development, Sales and Marketing Zubair Hussain, appointment, appointments, research and development, sales and marketing, topra
Pfizer UK’s Zubair Hussain has been appointed president-elect of global regulatory affairs organisation TOPRA.
Dr Jan Lundberg to succeed Dr Steven Paul as head of Lilly Research Laboratories
November 27, 2009Research and Development AstraZeneca, appointment, appt, lilly, research and development
Dr Jan Lundberg has been appointed executive VP, science and technology, and president of Lilly Research Laboratories.He will succeed Dr …
Actelion UK appoints Robin Bhattacherjee General Manager
November 4, 2009Research and Development, Sales and Marketing Actelion, appointment, research and development, sales and marketing
Actelion UK has appointed Robin Bhattacherjee general manager for the UK and Ireland. He will be based at the company’s …
Dr John Nash, Senior Director ADME/PK, BioFocus
November 3, 2009Research and Development appointment, biofocus, research and development
BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK. John has …
Claude Bertrand joins Ipsen as Chief Scientific Officer
October 27, 2009Research and Development appointment, ipsen, research and development
Ipsen has appointed Claude Bertrand (pictured) chief scientific officer and Jacques-Pierre Moreau chief scientific advisor.Bertrand moves to the company next …
Andrew Sandham, executive chairman, Syntaxin
October 20, 2009Research and Development appointment, appointments, research and development, syntaxin
Syntaxin, a biopharmaceutical company developing novel biologic drugs that control cell secretion, has appointed Andrew Sandham executive chairman.This follows the …
Cellectis appoints Dr Sylvie Delassus Senior Vice President Communications
October 20, 2009Research and Development appointment, cellectis, research and development
French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …
Dr Lisa Rojkjaer, head of clinical development, MorphoSys
October 15, 2009Research and Development appointment, morphosys, research and development
MorphoSys has appointed Dr Lisa Rojkjaer as vice president and head of clinical development. Dr Rojkjaer joins MorphoSys from Novartis …
